RE:News...PD001 gets approval!!This Sairiyo 49% subsidiary is now in play for merger and PharmaTher to acquire rest of of 51% and spin out this company publically..as stated by CEO many times. This Australian clincal trial approval is the catalysist to which a merger is required and for Sairiyo to go public and attract investor interest and financing that is required for Sairiyo. Sairiyo has a Market Cap of only $1million dollars with just over 100 million shares out, as of yesterday and today is seeing massive buying with this approval...See stock price go beyond .10 cents PLUS in the coming days and if PharmaTher acquires rest of 51% and goes public..see stock price over .25 cents very soon in my opinion. Saw opportunity a few months ago, just has they filed their application to the Australian authority. Still a great buying opportunity..